Lixin Zhang-Auberson

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

L. Kappos, C. Polman, P. Calabresi, 2010, The New England journal of medicine.

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

L. Kappos, E. Radue, E. Havrdová, 2012, The Lancet Neurology.

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study

Jeffrey A. Cohen, F. Barkhof, X. Montalban, 2011, The Lancet Neurology.

Chapter 223 – Neuregulins

K. Seroogy, L. Zhang-Auberson, J. Dickerson, 2013 .

Long-term effects of fingolimod in multiple sclerosis

L. Kappos, C. Polman, E. Radue, 2015, Neurology.

Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings.

Jeffrey A. Cohen, L. Kappos, G. Francis, 2014, Multiple sclerosis and related disorders.